1 / 51

Epidemiology and Prevention of Clostridium difficile

Epidemiology and Prevention of Clostridium difficile. W.I.P.E. Out Those Bugs May 2, 2014 Kavita K. Trivedi, MD Principal, Trivedi Consults, LLC Adjunct Clinical Professor of Medicine, Stanford University School of Medicine. Objectives.

austin-blankenship
Télécharger la présentation

Epidemiology and Prevention of Clostridium difficile

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epidemiology and Prevention of Clostridium difficile W.I.P.E. Out Those Bugs May 2, 2014 Kavita K. Trivedi, MD Principal, Trivedi Consults, LLC Adjunct Clinical Professor of Medicine, Stanford University School of Medicine

  2. Objectives • Describe the changing epidemiology of Clostridium difficile infections (CDI) in the United States • Review recent research on prevention of CDI • Discuss how to apply accepted infection prevention practices for CDI in healthcare settings

  3. Background • Gram positive, spore forming rod • Obligate anaerobe • Toxin A and Toxin B • Required to cause disease • Clostridium difficileinfection (CDI, formerly CDAD) • Most common cause of healthcare-associated diarrhea • Fecal-oral transmission • Can be community-associated

  4. Background: Adults • 2-5% of healthy adultshave C. difficile colonization of the colon • 20-40% of hospitalized adults are colonized with C. difficile

  5. Background: Children • Colonization rates of up to 70% have been reported in children < 1 year • By 2 years the ‘normal’ colonic flora is established and colonization decreases to the rate of healthy adults

  6. Epidemiology • Range from mild to severe • Starting in 2002, changes in C. difficilenoted, first in Quebec • Increased incidence (1991/19922003) • 36/100,0000156/100,000 • 65 and older: from 102/100,000 to 866/100,000 • Increased complications • Complicated disease: 7.1%18.2% • Death within 30 days: 4.7%13.8% Lisa Winston, MD; Pepin et al., CMAJ 2004;171:466-72

  7. C. DifficileInfection(CDI) • Incidence and severity have increased with dissemination of BI/NAP1 isolates • Historically uncommon – epidemic since 2000 • Increased virulence • Increased toxin A and B production • Polymorphisms in binding domain of toxin B • Increased sporulation • Increased resistance to fluoroquinolones • Higher MICs compared to historic strains and current non-BI/NAP1 strains • Early diagnosis and treatment are required to reduce morbidity/mortality McDonald et al. N Engl J Med. 2005;353:2433-41; Warnyet al.Lancet. 2005;366:1079-84 Stabler et al. J Med Micro. 2008;57:771–5; Akerlundet al. J ClinMicrobiol. 2008;46:1530–3

  8. Clostridium difficile Incidence and Mortality Are Increasing No. of CDI Cases per 10,000 Discharges Annual CD-related Mortality Rate per Million Population Elixhauser A, et al. Healthcare Cost and Utilization Project: Statistical Brief #50. April 2008. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb50.pdf. Accessed March 10, 2010. Redelings MD, et al. Emerg Infect Dis. 2007;13:1417-1419.

  9. Cost of CDI in US • CDI accounts for 336,000 hospitalizations annually • Aggregate hospital costs exceed $8.2 billion annually • Patients with principal CDI diagnosis remain hospitalized for 6.9 days at a cost of $10,100/stay • Patients with secondary CDI diagnosis remainhospitalized for 16.0 days at a cost of $31,500/stay. • CDI disproportionately affects the elderly • CMS pays for 68% of CDIhospital stays Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009. HCUP Statistical Brief124. January 2012. Rockville, MD: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf. Accessed December 27, 2011.

  10. Pathogenesis of CDI • Key steps • Acquisition of C. difficile • Alteration of colonic flora • Growth of C. difficile and elaboration of toxins • Poorly understood additional factor (s?) Gerding D N , Johnson S. CID 2010;51:1306-1313

  11. CDI Risk Factors • Antimicrobial exposure • Acquisition of C. difficile • Advanced age • Underlying illness • Immunosuppression • Tube feeds • ? Gastric acid suppression

  12. Risk Factors • Antimicrobial exposure • Acquisition of C. difficile • Advanced age • Underlying illness • Immunosuppression • Tube feeds • ? Gastric acid suppression Major modifiable risk factors

  13. C. difficile Hospital Epidemiology • Use of antibiotics is frequent • Environmental contamination by C. difficile is common • Spores are difficult to eradicate • Personnel carry C. difficile on their hands • Asymptomatic patients carry C. difficile

  14. Major Modifiable Risk Factors Gerding D N , Johnson S. CID 2010;51:1306-1313

  15. Major Modifiable Risk Factors Antibiotic Exposure Antibiotic Stewardship Acquisition of C. difficile Optimizing Environmental Cleaning and Hand Hygiene

  16. Antimicrobial Stewardship

  17. Antibiotic misuse adversely impacts patients - Clostridium difficile • Antibiotic exposure is the single most important risk factor for the development of Clostridium difficile associated disease (CDAD) • Up to 85% of patients with CDAD have antibiotic exposure in the 28 days before infection Chang HT et al. Infect Control Hosp Epidemiol 2007; 28:926–931.

  18. Antimicrobials Predisposing to CDI Bouza E, et al. Med Clin North Am. 2006;90:1141-1163. Loo VG, et al. N Engl J Med. 2005;353:2442-2449.

  19. Impact of Fluoroquinolone Optimization on Rates of Hospital-Onset CDI HO-CDAD cases/1,000 pd 2005 2006 2007 Month and Year Infect Control Hosp Epidemiol. 2009 Mar;30(3):264-72.

  20. 1980 – 2003 = 309 Studies 66 Studies had meaningful data analysis 16 Studies evaluated microbiologic outcomes 4 Studies – Favorable 8 Studies +/- 4 Studies—no effect

  21. Antimicrobial Stewardship Impact on C. difficile Disease

  22. ASP Make a Difference with Hospital-Associated CDI Tertiary Care Hospital; Québec, Canada (2003-2006) Valiquette, et al. Clin Infect Dis 2007;45:S112.

  23. ASP Community Hospital Example • Team: ID pharmacists, ID physicians • Target: 8 target antimicrobials • Interventions: Prospective audit of new antimicrobial starts and weekly use • Measure: Significant reductions in Clostridium difficile rates, antimicrobial utilization and pharmacy costs Malani, AN et al. Clinical and economic outcomes from a community hospital's antimicrobial stewardship program. American Journal of Infection Control 2012 May 9.

  24. Environmental Cleaning

  25. C. difficile and the Environment Level of contamination may be high Spores survive > 5 months Infective dose < 10 spores

  26. C. Difficile and the Environment Sethi et al. 2010

  27. C. Difficile and the Environment Sethi et al. 2010

  28. C. Difficile and the Environment

  29. Is the environment important in C. difficiletransmission?

  30. Persistence of spores • In multivariate analysis, OR for prior room occupant with CDI = 2.4 (1.2-4.5) • Adjusted for age, APACHE score, PPI, abx use… but not for length of stay Shaugnessy et al. Infect Control HospEpidemiol. 2011 Mar;32(3):201-6.

  31. Can disinfection cleaning decrease environmental contamination?

  32. Studies reporting a favorable impact of enhanced environmental hygiene during a CDI outbreak

  33. Culture based evaluation - Pre-intervention - after routine terminal cleaning - after terminal cleaning by the research staff - following education of the ES staff and administrative interventions

  34. Bedrail Bedside table Phone Call button Toilet Door handle 80 70 60 50 40 Percent positive 30 20 10 0 After housekeeping cleaning After disinfection by research team* Before cleaning Percentage of C. difficile-positive cultures n=9 rooms *Similar results found after ES cleaning following interventions Eckstein et al, BMC Infect Dis. 2007 Jun 21;7:61.

  35. Can improved disinfection/cleaning lead to decreased CDI?

  36. Greater New York CDI Collaborative • 40 Hospitals – New York area, 2007-2009 • Pre-intervention rate – 8.1/ 10,000 PtD • Similar education, check sheet and self reporting of thoroughness of terminal cleaning. Glitterbug lotion used for some teaching (not monitoring). • 70% of Hospitals saw an average decrease of 26% in HO CDI (Mean for the system = 15%) Source: Barbra Smith, RN CIC and Brian Koll, M.D. project Coordinators. APIC presentation.

  37. Prevention Strategies

  38. CDC Prevention Strategies Supplemental Strategies Core Strategies • High levels of scientific evidence • Demonstrated feasibility • Some scientific evidence • Variable levels of feasibility

  39. Environmental Cleaning Supplemental Core • Cleaning and disinfection of equipment and environment • Consider sodium hypochlorite in outbreak or hyper endemic settings • Routinely assess adherence to protocols and adequacy of cleaning • Reassess adequacy of room cleaning and address issues • Use sodium hypochlorite (bleach) – containing agents www.cdc.gov/ncidod/dhqp/id_CdiffFAQ_HCP.html Dubberke et al. Infect Control Hosp Epidemiol 2008;29:S81-92 Cohen et al. Infect Control Hosp Epidemiol 2010;31

  40. Contact Precautions Core Supplemental • Gloves/gowns on room entry • Private room (preferred) or cohort with dedicated commodes • Dedicated equipment • Maintain for duration of diarrhea • Measure compliance • Extend use of Contact Precautions beyond duration of diarrhea (hospitalization) • Presumptive isolation • Universal glove use on units with high CDI rates • Intensify assessment of compliance

  41. Hand Hygiene Supplemental Core • Soap and water for hand hygiene before exiting room of a patient with CDI • Intensify assessment of compliance • Hand hygiene based on CDC or WHO guidelines • Soap and water preferentially in outbreak or hyper endemic settings • Measure compliance

  42. Diagnostic Testing Core Supplemental • Laboratory-based alert system for immediate notification of positive test results • Evaluate and optimize testing for CDI

  43. Evaluate and Optimize Testing for CDI • Toxin A/B enzyme immunoassays have low sensitivities (60-80%) • Despite high specificity, poor test ordering practices (i.e. testing formed stool) may lead to false positives • Consider more sensitive diagnostic paradigms but apply judiciously • Restrict testing to unformed stool only • Focus testing on patients with > 3 unformed stools within 24 hours • Repeat testing no more than every 5-7 days if negative • Require expert consultation for repeat testing within 5 days • Test of cure is not recommended Peterson et al. Ann Intern Med 2009;15:176-9. Cohen et al. Infect Control Hosp Epi 2010; 31 (5): 431-455.

  44. Two-Step Testing • Utility related to • Sensitivity of initial screen • Sensitivity of GDH EIA screen 76% to 100% • Cost of confirmatory test alone versus screen plus confirmatory test • Cost of false positive test (not quantified) • Promoted to enhance sensitivity • Actually enhances positive predictive value of confirmatory test • Increased prevalence of disease

  45. CDI is the most serious, frequent and costly HAI Decreased antibiotic exposure and stewardship optimization are important in preventing CDI Optimizing environmental hygiene is becoming recognized as central to controlling CDI All hospitals should be in compliance with CDC Core Recommendations Conclusions

  46. CDI and Infection control • Gloves + gowns for duration of diarrhea • Wash with soap and water (epidemic setting) • Private rooms • Dedicated commode • Bleach cleaning • Antimicrobial stewardship Cohen et al., Infection Control and Hospital Epidemiology, 2010; 31: 431-455

More Related